ACTRN12611000845932已完成4 期
Safety and efficacy of high dose allopurinol in the management of gout: a randomised interventional study
isa Stamp0 个研究点目标入组 200 人开始时间: 2011年8月10日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients with gout, as defined by the American College of Rheumatology Criteria, receiving at least the CrCL-based dose of allopurinol for at least one month and with a SU greater than or equal to 0.36mmol/L will be recruited.
排除标准
- •Patients with a history of intolerance to allopurinol and patients receiving azathioprine
研究者
相似试验
已完成
不适用
A pilot study of high dose allopurinol in the management of gout:GoutInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12606000276550isa Stamp100
招募中
3 期
The Effect of Allopurinol on Percutaneous Coronary Intervention Outcomes in ST-segment Elevation Myocardial Infarction PatientsPrecancerous Coronary Intervention Outcome.ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarctionIRCT20181228042155N1Esfahan University of Medical Sciences80
已完成
3 期
Effect of Allopurinol in treatment of patients with Non ST-segment elevation myocardial infarctioAcute myocardial infarction without ST segment elevation.Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarctionIRCT20191223045866N1Esfahan University of Medical Sciences80
进行中（未招募）
1 期
Estudio para valorar el efecto sobre las plaquetas del tratamiento con Alopurinol en pacientes diabéticosEUCTR2011-000619-16-ESFundación Investigación Biomedica. Hospital Clinico San Carlos
已完成
3 期
Evaluation of allopurinol efficacy in patients with nonalcoholic fatty liver diseasenonalcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classifiedIRCT20160920029889N1Oroumia University of Medical Sciences44